Home International BioAsia 2023 Announces a stellar speaker line-up to discuss the learnings, challenges and opportunities in Life Science post-COVID-19

BioAsia 2023 Announces a stellar speaker line-up to discuss the learnings, challenges and opportunities in Life Science post-COVID-19

by News Monks

The pandemic has brought into sharp focus the critical need for industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation at scale and delivery with equitable access. In this context, the 20th edition of BioAsia – the marquee healthcare and Life Sciences event, organized by the Government of Telangana, will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare. The event is scheduled to be held between February 24 and 26, 2023 at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event.


Moving back to a in-person format, Asia’s largest life-sciences and healthcare forum BioAsia 2023, will witness the participation of some of the most renowned and influential global leaders including:


Dr. Vas (Vasanth) Narasimhan, CEO, Novartis, Switzerland (Admired global leader with extensive work on a range of public health issues including development of over 20 novel medicines, advance cell and gene therapies and vaccines. He is also a member of the U.S. National Academy of Medicine and a member of the board of fellows of Harvard Medical School. In 2015, Fortune listed him 7th in their ’40 under 40′ list.)

Prof. Robert Langer, Prof. at MIT And Co-Founder, Moderna, Inc., USA (A scientist, entrepreneur, professor at MIT and co-founder Moderna Therapeutics with 37 honorary doctorates. He has been awarded the US National Medal of Science, US National Medal of Technology and Innovation, Queen Elizabeth Prize for Engineering. Max Planck Research Award, among others. He has also been named as one of the 25 most important individuals in biotechnology in the world by Forbes and by Time Magazine and CNN as one of the 100 most important people in US.)

Dr. Richard Hatchett, CEO, CEPI (Coalition for Epidemic Preparedness Innovations), UK (Previously the acting Director of U.S Biomedical Advanced Research and Development Authority (BARDA), a consultant to the WHO on a variety of topics related to biodefense and emergency medical preparedness and also served as Director for Medical Preparedness Policy on the White House National Security Staff and was conferred the United States secretary of health and human services award)

Dr. Rahul Singhvi, CEO, Resilience, USA (A global leader in the Life Sciences industry was formerly the Chief Operating Officer at Takeda’s Vaccine Business Unit and the President and CEO of Novavax. He was also an Operating Partner at Flagship Pioneering, a Boston-based life-sciences innovation firm with over 100 portfolio biotech companies including Moderna)

Dr. Mark Abdoo, Associate Commissioner for Global Policy and Strategy, US-FDA (providing executive oversight, strategic leadership and policy direction to FDA’s global policy, operations, trade, and diplomacy activities)

Dr. Gregory Moore, Vice President of Corporate Planning at Microsoft, USA (leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences.)

Prof. Sarfaraz K. Niazi, Adj. Professor of Pharmaceutical Sciences, University of Illinois, Chicago, USA (Adviser to 6 heads of State including President Barack Obama, Pioneer in Biosimilars, Established first US biosimilars company and holds 200+patents, an inductee in entrepreneur hall of fame and has raised over $500 Mn)

Dr. Samit Hirawat, Executive Vice President and Chief Medical Officer for the Global Drug Development division, Bristol-Myers Squibb, USA;

Dr. Sarah Mcmullen, Country Director – India, FDA

Dr. Soumya Swaminathan, Chief Scientist, World Health OrgaOrganization

Dr. Shyam Bishen, Executive Director for Shaping the Future of Health and Healthcare, World Economic Forum, Switzerland

Mr. Agam Upadhyay, SVP, Chief Technology Officer, GSK, USA

Mr. Pavan Kumar Mocherla, MD India And South Asia, BD, Singapore



You may also like

Leave a Comment

Introducing NewsMonks, your premier source for comprehensive and concise news coverage. Dive into the world of business news, alongside a diverse range of other current topics. Stay informed, stay ahead with NewsMonks. Your go-to destination for news that matters.


Contact : +91 6351857103 (WA Only)

Email: newsmonnks@gmail.com 


Live Traffic

Edtior's Picks

All Rights Reserved by NewsMonks @2023.,
Powered by MediaHives.com